Few phrases generate more heat and less light than “leaky gut.” In wellness marketing it is a catch-all cause of nearly everything; in some clinical quarters it is dismissed as pseudoscience. Both framings obscure a real and well-studied physiological concept: intestinal permeability.
The barrier is real
The single-cell epithelial layer lining the gut is sealed by protein complexes called tight junctions, which regulate what crosses between the gut lumen and the bloodstream. This barrier is dynamic, not fixed, and its permeability can increase — demonstrably — under certain conditions. Reviews in Gut and BMC Gastroenterology have laid out the mechanisms and the measurement methods (such as dual-sugar absorption tests).
Where the evidence is solid — and where it isn’t
Increased permeability is well documented in defined conditions including coeliac disease, inflammatory bowel disease and some infections. What remains an open research question is the direction of causation in many other settings: whether increased permeability drives systemic disease, or is a downstream consequence of it, is frequently unresolved.
The barrier is real and measurable. “Leaky gut syndrome” as a stand-alone diagnosis that explains diffuse symptoms is not an established clinical entity.
So the scientifically defensible position is narrow but firm: intestinal permeability is a legitimate, measurable variable under active study; the popular “leaky gut syndrome” — a single condition causing fatigue, brain fog and the rest — is not a recognized diagnosis, and products marketed to “seal” the gut are running well ahead of the evidence.
Frequently asked
Is leaky gut a real condition?
Increased intestinal permeability is a real, measurable physiological phenomenon documented in conditions such as coeliac disease and inflammatory bowel disease. “Leaky gut syndrome” as a stand-alone diagnosis explaining diffuse, non-specific symptoms is not an established clinical entity.
What are the symptoms of increased intestinal permeability?
Permeability changes are typically identified by laboratory measurement, not a specific symptom set. In the conditions where it is documented, it accompanies the underlying disease rather than presenting as its own symptom cluster.
How is intestinal permeability measured?
Research settings commonly use dual-sugar absorption tests (for example lactulose/mannitol ratios) and biomarkers such as zonulin, though the interpretation and validity of some markers remain debated.